plasmacytoid dendritic cells in atherosclerosis
Clicks: 238
ID: 237799
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
238 views
46 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #342 of 461 articles by views in Journal of clinical and experimental dentistry
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 461 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Atherosclerosis, a chronic inflammatory disease of the vessel wall and the underlying cause of cardiovascular disease, is initiated and maintained by innate and adaptive immunity. Accumulating evidence suggests an important contribution of autoimmune responses to this disease. Plasmacytoid dendritic cells (pDCs), a specialized cell type known to produce large amounts of type I interferons in response to bacterial and viral infections, have recently been revealed to play important roles in atherosclerosis. For example, the development of autoimmune complexes consisting of self-DNA and antimicrobial peptides, which trigger chronic type I interferon production by pDCs, promote early atherosclerotic lesion formation. pDCs and pDC-derived type I interferons can induce the induce the maturation of conventional DCs and macrophages, and the development of auto-reactive B cells and antibody production. These mechanisms, known to play a role in the pathogenesis of other autoimmune diseases such as SLE and psoriasis, may also affect the development and progression of atherosclerotic lesion formation. This review discusses emerging evidence showing a role for pDCs in the onset and progression of atherosclerosis.
| Reference Key |
edring2012frontiersplasmacytoid
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Yvonne eDöring;Alma eZernecke |
| Journal | Journal of clinical and experimental dentistry |
| Year | 2012 |
| DOI |
10.3389/fphys.2012.00230
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.